Research Article

Shenzhiling Oral Liquid Protects STZ-Injured Oligodendrocyte through PI3K/Akt-mTOR Pathway

Figure 4

Effect of SZL-medicated serum on expression of PI3K (a), Akt (b), p-Akt (c), mTOR (d), and p-mTOR (e) proteins in injured OLN-93 cells. C, control group; M, model group; Don, donepezil group; SZL, SZL-medicated serum group. , significantly different from control group; , significantly different from model group. Each point represents the mean ± SD of n = 6 experiments.
(a)
(b)
(c)
(d)
(e)